Otsuka Holdings
4578.T
#750
Rank
โ‚น2.804 T
Marketcap
โ‚น5,310
Share price
0.21%
Change (1 day)
8.94%
Change (1 year)
Otsuka Pharmaceutical Co., Ltd. is a Japanese pharmaceutical company involved in the R&D of drugs and healing methods for respiratory diseases, eye diseases, cardiovascular diseases, neurological and mental diseases as well as Parkinson's, tuberculosis and cancer.

Earnings for Otsuka Holdings (4578.T)

Earnings in 2023: โ‚น94.71 Billion

According to Otsuka Holdings 's latest financial reports the company's current earnings are โ‚น14.47 Billion. In 2023 the company made an earning of โ‚น94.71 Billion a decrease over its 2022 earnings that were of โ‚น119.78 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Otsuka Holdings from 2010 to 2023

Annual earnings

Year Earnings Change
2023โ‚น94.71 B-20.93%
2022โ‚น119.78 B-12.7%
2021โ‚น137.21 B-19.92%
2020โ‚น171.35 B13.9%
2019โ‚น150.44 B52.07%
2018โ‚น98.93 B11.22%
2017โ‚น88.95 B-36.03%
2016โ‚น139.05 B31.15%
2015โ‚น106.02 B
2013โ‚น220.06 B33.52%
2012โ‚น164.81 B-4.65%
2011โ‚น172.85 B45.53%
2010โ‚น118.78 B